IP Library Granted Patent US 9,018,241
Granted Patent B2
US 9,018,241 · App. 13/716,474 · Granted Apr 28, 2015

Hetero-substituted acetanilide derivatives as analgesic agents

Inventors: John R. Carson (Norristown, PA); James J. McNally (Souderton, PA)
Assignee: Janssen Pharmaceutica, NV
C07D233/90C07D231/56A61K31/44A61K31/495C07D207/34C07D231/14A61K31/537A61K31/40A61K31/16A61K31/54C07D213/81C07D207/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,018,241
App. No.
13/716,474
Granted
Apr 28, 2015
Kind
B2
Abstract

Hetero-substituted acetanilide derivatives are disclosed as analgesic agents. The compounds of the invention are useful in methods for treating a disease or condition in a mammal characterized by pain and/or fever.

Claims (10)

1. A compound selected from the group consisting of:

5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide; and

3H-Imidazole-4-carboxylic acid (4-hydroxy-phenyl)-amide;

and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

2. A compound of claim 1 , wherein the compound is 5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

3. A composition comprising a compound selected from the group consisting of:

5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide; and

3H-Imidazole-4-carboxylic acid (4-hydroxy-phenyl)-amide;

and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

4. The composition of claim 3 wherein the compound is 5-Methyl-1H-pyrazole-3-carboxylic acid (4-hydroxy-phenyl)-amide and enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: CARSON, JOHN R.; MCNALLY, JAMES J.
To: JANSSEN PHARMACEUTICA, N.V.
Reel/Frame 048168/0296 →
Continuity (4)
Division 12751382 · Mar 31, 2010
Division 10778980 · Feb 13, 2004
Provisional Application 60439761 · Jan 13, 2003
Related Publication 20130109863A1 · May 2, 2013